Effects of narrow-band ultraviolet B and tazarotene therapy on keratinocyte proliferation and TIG3 expression

Journal of Dermatology

Volumn 35, Issue 10, 2008, Pages 651-657

  Luo, Suju ^a   Zheng, Yan ^a   Peng, Zhenhui ^a   Jiang, Ju ^c   Gondokaryono, Srie ^c   Wang, Guorong ^b   Ikeda, Shigaku ^c  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

Keratinocyte; Narrow band ultraviolet B therapy; Proliferation; Tazarotene; Tazarotene induced gene

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MESSENGER RNA; PROTEIN TIG3; RETINOIC ACID RECEPTOR; TAZAROTENE; UNCLASSIFIED DRUG;

ARTICLE; CALORIMETRY; CELL CULTURE; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INCUBATION TIME; KERATINOCYTE; PROTEIN EXPRESSION; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT INDICATION; ULTRAVIOLET B RADIATION;

CELL PROLIFERATION; CELLS, CULTURED; DERMATOLOGIC AGENTS; HUMANS; KERATINOCYTES; NICOTINIC ACIDS; RECEPTORS, RETINOIC ACID; ULTRAVIOLET RAYS;

EID: 54349120035     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2008.00538.x     Document Type: Article

References (22)

1. Boudjelal M, Voorhees JJ, Fisher GJ. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells. Exp Cell Res 2002 274 : 130 137.
2. Bianchi L, Orlandi A, Campione E et al. Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases. Br J Dermatol 2004 151 : 148 156.
3. Weinstein G, Krueger GG, Lowe NJ et al. Tazarotene gel, a new retinoid, for topical therapy of psoriasis. Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. J Am Acad Dermatol 1997 37 : 85 92.
4. Duvic M, Nagpal S, Asano AT et al. Molecular mechanisms of tazarotene action in psoriasis. J Am Acad Dermatol 1997 37 : S18 24.
5. Duvic M, Ni X, Talpur R et al. Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. J Invest Dermatol 2003 121 : 902 909.
6. Wu CC, Shyu RY, Chou JM et al. RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma. Eur J Cancer 2006 42 : 557 565.
7. Duvic M, Helekar B, Schulz C et al. Expression of a retinoid-inducible tumor suppressor, tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res 2000 6 : 3249 3259.
8. Bandow GD, Koo JY. Narrow-band ultraviolet B radiation: a review of the current literature. Int J Dermatol 2004 43 : 555 561.
9. Inui S, Nishida Y, Itami S et al. Disseminated granuloma annulare responsive to narrowband ultraviolet B therapy. J Am Acad Dermatol 2005 53 : 533 534.
10. Schiener R, Behrens-Williams SC, Pillekamp H et al. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis. Br J Dermatol 2000 143 : 1275 1278.
11. Howell BG, Wang B, Freed I et al. Microarray analysis of UVB-regulated genes in keratinocytes: downregulation of angiogenesis inhibitor thrombospondin-1. J Dermatol Sci 2004 34 : 185 194.
12. Aufiero BM, Talwar H, Young C et al. Narrow-band UVB induces apoptosis in human keratinocytes. J Photochem Photobiol 2006 82 : 132 139.
13. Seqaert S, Garmyn M, Bouillon R et al. Subpharmacological concentrations of retinoic acid attenuate the antiproliferative effect of calcitriol on cultured human keratinocytes. J Eur Acad Dermatol Venereol 1995 5 : 91.
14. -ΔΔCT method. Methods 2001 25 : 402 408.
15. DiSepio D, Ghosn C, Eckert RL et al. Identification and characterization of a retinoid-inducible class II tumor suppressor/antiproliferative gene. Proc Natl Acad Sci 1998 95 : 14811 14815.
16. Jiang SY, Chou JM, Leu FJ et al. Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma. World J Gastroenterol 2005 11 : 948 953.
17. Higuchi E, Chandraratna RA, Hong WK et al. Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype. Oncogene 2003 22 : 4627 4635.
18. Huang SL, Shyu RY, Yeh MY et al. Cloning and characterization of a novel retinoid-inducible gene 1 (RIG1) deriving from human gastric cancer cells. Mol Cell Endocrinol 2000 159 : 15 24.
19. Takasawa R, Tanuma S. Sustained release of Smac/DIABLO from mitochondria commits to undergo UVB-induced apoptosis. Apoptosis 2003 8 : 291 299.
20. Sitailo LA, Tibudan SS, Denning MF. Activation of caspase 9 is required for UV-induced apoptosis of human keratinocytes. J Biol Chem 2002 277 : 19346 19352.
21. Lewis DA, Hurwitz SA, Spandau DF. UVB-induced apoptosis in normal human keratinocytes: role of the erbB receptor family. Exp Cell Res 2003 284 : 316 327.
22. Tsai FM, Shyu RY, Jiang SY. TIG3 inhibits the Ras/mitogen-activated protein kinase pathway by suppressing the activation of Ras. Cell Signal 2006 18 : 349 358.